ED  Massachusetts Life Sciences Center


     Office Locations:

1000 Winter Street, Suite 2900
Waltham, MA 02451
Phone: 781-373-7777
Fax: 781-622-1530



  • Early
  • Seed



  • Life Sciences & Healthcare



    The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the Commonwealth of Massachusetts, created by the Massachusetts legislature in June 2006. The MLSC was established to promote the life sciences within the Commonwealth of Massachusetts. It is tasked with investing in life sciences research and economic development. This work includes making financial investments in public and private institutions growing life sciences research, development and commercialization, as well as building ties between sectors of the Massachusetts life sciences community. Funding initiatives include Massachusetts Life Science Fellowship Grants (Gap Funding) to promote new cures and retain researchers in Massachusetts; NIH gap funding grants to bridge researchers prior to receipt of NIH grant; Stem Cell research funding to overcome federal prohibitions and leverage Massachusetts' existing global strength in stem cell research; and RNAi funding to build upon the promising work of UMass Nobel laureate, Dr. Craig Mello. Through another initiative, the Life Sciences Accelerator Program, the MLSC will provide loans to companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Beth Nicklas Esq. VP and Counsel for Academic Research and Programs
    Bradley Rosenblum Chief Financial and Administrative
    Pamela Norton Vice President for Industry Relations and Programs
    Susan Windham-Bannister Ph.D. President and CEO


    Portfolio companies include:

      Good Start Genetics
        web link

      InVivo Therapeutics
        web link

        web link

      Wadsworth Medical
        web link


    Recent News: